Screening algorithms for HBV, HCV, HIV and syphilis in an anatomical donation program

被引:2
|
作者
Valcke, Brecht [1 ]
Vercauteren, Koen [2 ]
Padalko, Elizaveta [3 ]
Verhofstede, Chris [4 ]
D'Herde, Katharina [1 ]
Willaert, Wouter [1 ]
机构
[1] Univ Ghent, Dept Human Struct & Repair, Corneel Heymanslaan 10, B-9000 Ghent, Belgium
[2] Inst Trop Med, Clin Virol Unit, Clin Reference Lab, Kronenburgstr 43, B-2000 Antwerp, Belgium
[3] Ghent Univ Hosp, Lab Med Microbiol, Corneel Heymanslaan 10, B-9000 Ghent, Belgium
[4] Univ Ghent, Dept Diagnost Sci, Aids Reference Lab, Corneel Heymanslaan 10, B-9000 Ghent, Belgium
关键词
Anatomy; Cadaver; Embalming; Hemolysis; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-B; POSTMORTEM VIABILITY; TREPONEMA-PALLIDUM; BLOOD-SAMPLES; CADAVER; TRANSMISSION; PREVALENCE; SURVIVAL; DISCARDS;
D O I
10.1016/j.aanat.2021.151805
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Background: Users of anatomical donors are at risk of exposure to bloodborne pathogens. This study evaluated screening algorithms for hepatitis B and C virus, human immunodeficiency virus and Treponema pallidum during donor allocation and assessed the impact of postmortem time on hemolysis and how hemolysis affects test results and donor discard rate. Methods: From 2011 to 2018, demographic data of anatomical donors, time of postmortem blood sampling, presence of sample hemolysis, serological test results (negative; active infection; false reactive screening test; historic infection; inconclusive; technically impracticable) and the actual donor allocation were collected. Results: Donors (n = 537) had a mean age of 77.53 +/- 13.67 (24-103) year. Nine (1.68%) had laboratory test results indicative for active infection for hepatitis B (n = 1) and C virus (n = 2), human immunodeficiency virus (n = 5) and T. pallidum (n = 1). Negative screenings ranged from 74.67 to 97.58%, depending on the pathogen. According to the original screening algorithms, 479 (89.20%) donors should have been accepted. In practice, a donor acceptance rate of 91.20% was found. Analysis of potential donor allocation interpretation obstacles resulted in simplification of the in-house laboratory testing algorithms and addition of a nucleic acid test to increase the reliability for identification of active (acute) human immunodeficiency virus infection. Hemolysis was more common when sampling was performed more than 24 h after death (p < 0.001). Hemolytic samples more frequently showed a reactive or indeterminate human immunodeficiency virus test result (p < 0.001). Screening for human immunodeficiency virus and T. pallidum was technically more impracticable when hemolysis was present (p = 0.042 and p = 0.003, respectively). Donors with hemolytic blood samples were more often discarded (46.88%) compared to bodies with non-hemolytic samples (6.32%) (p < 0.001). Conclusions: Despite the implementation of donor screening algorithms, a significant number of bodies have an inconsistent allocation. New algorithms, to be evaluated in future research, were suggested. Early postmortem blood sampling is key as hemolysis can influence certain test results and donor allocation. (c) 2021 Elsevier GmbH. All rights reserved.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] NAT SCREENING FOR HIV/HCV/HBV IN CENTRAL PORTUGAL (2005-2009)
    Teixeira, M.
    Henggeler, F.
    Castro, R.
    Mateus, N.
    Jeronimo, S.
    Goncalves, M.
    VOX SANGUINIS, 2010, 99 : 273 - 273
  • [32] Cost-effectiveness of screening donated blood with NAT for HBV, HCV and HIV
    Kleinman, S
    Aubuchon, JP
    Marshall, DA
    Wong, JB
    Grima, D
    Weinstein, MC
    TRANSFUSION, 2001, 41 (09) : 1S - 1S
  • [33] SEROCONVERSION SENSITIVITY OF ELISA SCREENING ASSAYS FOR HCV, HIV AND HBV ANTIGENS AND/OR ANTIBODIES
    Cucchietti, A.
    Parker, S.
    Oldfield, L.
    Limas, C.
    Garrod, A.
    Mc Bryne, L.
    VOX SANGUINIS, 2011, 101 : 87 - 87
  • [34] Prevalence and risk of HCV transmission after screening for HIV and HBV in blood donnors
    Dagnra, A
    Prince-David, A
    Agbénu, S
    Ouro-Akpo, T
    Hounkpati, F
    MEDECINE ET MALADIES INFECTIEUSES, 2002, 32 (06): : 315 - 316
  • [35] HCV, HIV-1, HBV molecular screening for blood donation: From semi-automate systems to the fully automated instrument platform
    Mannella, E.
    Iudicone, P.
    Palange, M.
    Agresti, A.
    Colaceci, R.
    Tudisco, A.
    Amedeo, C.
    Berardini, S.
    Miceli, M.
    VOX SANGUINIS, 2006, 91 : 84 - 85
  • [36] Prevalence of HBV, HCV, HIV, and Syphilis among Homeless Subjects Older than Fifteen Years in Tehran
    Vahdani, Parviz
    Hosseini-Moghaddam, Seyed-Mohammadmehdi
    Family, Alireza
    Moheb-Dezfouli, Ramin
    ARCHIVES OF IRANIAN MEDICINE, 2009, 12 (05) : 483 - 487
  • [37] The migration project in Veneto Region: evaluation of epidemiological impact of Tubercolosis, HIV, HBV, HCV infections and syphilis
    Morelli, E.
    Disegna, M.
    Gennaro, N.
    Gallo, C.
    Raise, E.
    INFECTION, 2010, 38 : 29 - 29
  • [38] Prevalence of HIV, HBV, HCV, HPV and syphilis among female sex workers in Kurdistan, west of Iran
    Bashmaq, Somaye Mafakheri
    Ahmadi, Amjad
    Mohsenpour, Behzad
    Rahmani, Khaled
    Arasteh, Modabber
    Alizadeh, Narges Shams
    Babahajian, Asrin
    Advay, Shoaib
    Abbaszadeh, Asefeh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2024, 15 (01) : 38 - 45
  • [39] HCV, HBV AND HIV IN DRUG ADDICTS
    Lawental, Eli
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (03): : 193 - 194
  • [40] Comparison of HBV DNA results detected by 5 HBV/HCV/HIV-1 blood screening kits
    Wu, X.
    Zhou, C.
    Gu, W. -J.
    Lan, H. -Y.
    Liang, Z. -L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S60 - S60